102 related articles for article (PubMed ID: 2222519)
21. Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells.
Ganapathi R; Yen A; Grabowski D; Schmidt H; Turinic R; Valenzuela R
Br J Cancer; 1986 Apr; 53(4):561-6. PubMed ID: 3707847
[No Abstract] [Full Text] [Related]
22. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y
Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
[TBL] [Abstract][Full Text] [Related]
23. Modulation of adriamycin and N-trifluoroacetyladriamycin-14-valerate induced effects on cell cycle traverse and cytotoxicity in P388 mouse leukemia cells by caffeine and the calmodulin inhibitor trifluoperazine.
Ganapathi R; Grabowski D; Schmidt H; Yen A; Iliakis G
Cancer Res; 1986 Nov; 46(11):5553-7. PubMed ID: 3756902
[TBL] [Abstract][Full Text] [Related]
24. Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933.
Alaoui Jamali MA; Yin MB; Mazzoni A; Bankusli I; Rustum YM
Cancer Chemother Pharmacol; 1989; 25(2):77-83. PubMed ID: 2598402
[TBL] [Abstract][Full Text] [Related]
25. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: II. DNA damage, repair and chromatin changes.
Smith PJ; Mircheva J; Bleehen NM
Br J Cancer; 1986 Jan; 53(1):105-14. PubMed ID: 2418859
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells.
Ramachandran C; You W; Krishan A
Anticancer Res; 1997; 17(5A):3369-76. PubMed ID: 9413174
[TBL] [Abstract][Full Text] [Related]
27. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
Tapiero H; Nguyen-Ba G; Lampidis TJ
Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
[TBL] [Abstract][Full Text] [Related]
28. Anthracycline-induced DNA breaks and resealing in doxorubicin-resistant murine leukemic P388 cells.
Maniar N; Krishan A; Israel M; Samy TS
Biochem Pharmacol; 1988 May; 37(9):1763-72. PubMed ID: 2837239
[TBL] [Abstract][Full Text] [Related]
29. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: I. In vitro cytotoxicity.
Mircheva J; Smith PJ; Bleehen NM
Br J Cancer; 1986 Jan; 53(1):99-103. PubMed ID: 2418860
[TBL] [Abstract][Full Text] [Related]
30. Trifluoperazine prevents FOXO1 nuclear excretion and reverses doxorubicin-resistance in the SHG44/DOX drug-resistant glioma cell line.
Chen X; Luo X; Cheng Y
Int J Mol Med; 2018 Dec; 42(6):3300-3308. PubMed ID: 30272254
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of membrane currents and rises of intracellular Ca2+ in PC12 cells by CGS 9343B, a calmodulin inhibitor.
Neuhaus R; Reber BF
Eur J Pharmacol; 1992 Jun; 226(2):183-5. PubMed ID: 1379190
[TBL] [Abstract][Full Text] [Related]
32. Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial.
Miller RL; Bukowski RM; Budd GT; Purvis J; Weick JK; Shepard K; Midha KK; Ganapathi R
J Clin Oncol; 1988 May; 6(5):880-8. PubMed ID: 3367191
[TBL] [Abstract][Full Text] [Related]
33. Suppression of P-glycoprotein expression by antipsychotics trifluoperazine in adriamycin-resistant L1210 mouse leukemia cells.
Shin SY; Choi BH; Kim JR; Kim JH; Lee YH
Eur J Pharm Sci; 2006 Jul; 28(4):300-6. PubMed ID: 16707254
[TBL] [Abstract][Full Text] [Related]
34. [Effect of calmodulin antagonist on chemosensitivity of primary cultured lung cancer cells].
Xiong W; Shen H
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):347-9. PubMed ID: 8697972
[TBL] [Abstract][Full Text] [Related]
35. CGS 9343B and W7 (calmodulin antagonists) inhibit KCl-induced increase in cytosolic free calcium and insulin secretion of RINm5F cells.
Safayhi H; Kühn M; Koopmann I; Ammon HP
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):8-13. PubMed ID: 2657441
[TBL] [Abstract][Full Text] [Related]
36. Can cytotoxic activity of anthracyclines be related to DNA damage?
Nishiyama M; Horichi N; Mazouzi Z; Bungo M; Saijo N; Tapiero H
Anticancer Drug Des; 1990 Feb; 5(1):135-9. PubMed ID: 2317255
[TBL] [Abstract][Full Text] [Related]
37. Calmodulin antagonists decrease glucose 1,6-bisphosphate, fructose 1,6-bisphosphate, ATP and viability of melanoma cells.
Glass-Marmor L; Morgenstern H; Beitner R
Eur J Pharmacol; 1996 Oct; 313(3):265-71. PubMed ID: 8911923
[TBL] [Abstract][Full Text] [Related]
38. Abnormally banded chromosomal regions in doxorubicin-resistant B16-BL6 murine melanoma cells.
Slovak ML; Hoeltge GA; Ganapathi R
Cancer Res; 1986 Aug; 46(8):4171-7. PubMed ID: 3731084
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
Ganapathi R; Grabowski D
Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140
[TBL] [Abstract][Full Text] [Related]
40. Effects of KW-5617 (zaldaride maleate), a potent and selective calmodulin inhibitor, on secretory diarrhea and on gastrointestinal propulsion in rats.
Aikawa N; Karasawa A
Jpn J Pharmacol; 1998 Feb; 76(2):199-206. PubMed ID: 9541283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
